VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $322 | -99.9% | 43,517 | -1.3% | 0.04% | -27.4% |
| Q3 2022 | $436,000 | -9.2% | 44,082 | 0.0% | 0.06% | -3.1% |
| Q2 2022 | $480,000 | -3.8% | 44,082 | 0.0% | 0.06% | +23.1% |
| Q1 2022 | $499,000 | -27.9% | 44,082 | 0.0% | 0.05% | -17.5% |
| Q4 2021 | $692,000 | -8.5% | 44,082 | 0.0% | 0.06% | -10.0% |
| Q3 2021 | $756,000 | -20.3% | 44,082 | 0.0% | 0.07% | -13.6% |
| Q2 2021 | $948,000 | +43.2% | 44,082 | 0.0% | 0.08% | +35.0% |
| Q1 2021 | $662,000 | +155.6% | 44,082 | +123.7% | 0.06% | +160.9% |
| Q4 2020 | $259,000 | +36.3% | 19,710 | +0.1% | 0.02% | +27.8% |
| Q3 2020 | $190,000 | -15.6% | 19,685 | 0.0% | 0.02% | -14.3% |
| Q2 2020 | $225,000 | +19.7% | 19,685 | +8.3% | 0.02% | +10.5% |
| Q1 2020 | $188,000 | -82.6% | 18,180 | -56.1% | 0.02% | -71.6% |
| Q4 2018 | $1,082,000 | – | 41,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |